| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |